Antibe Therapeutics Inc. announced the formation of its Clinical Advisory Board with the appointment of three distinguished, internationally recognized gastroenterologists. The three appointees are: Dr. Francis Chan, Professor of Medicine at The Chinese University of Hong Kong; Dr. Angel Lanas, Professor of Medicine, University of Zaragoza (Spain); and Dr. James Scheiman, Professor of Internal Medicine at the University of Michigan. The company also announced that Jeremy Grushcow, Ph.D., J.D. has moved to a full-time position as EVP, Strategic Development.
Antibe Therapeutics Inc.
Equities
ATE
CA0370255097
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+19.18% | 125B | |
+14.04% | 108B | |
-4.09% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-12.51% | 16.5B | |
+2.60% | 13.39B | |
+27.22% | 11.1B |